Denali Therapeutics

Dec 31, 2024

Parkinson's disease is a progressive neurodegenerative disorder that affects nearly 10 million people worldwide. With the increasing prevalence of Parkinson's disease due to aging populations and environmental risk factors, this condition profoundly impacts motor functions, cognitive abilities, and overall quality ...

May 22, 2020

The Hunter Syndrome Market is expected to grow with CAGR of 7.5% in the coming years in the 7MM. Occurring in approximately 1 in 100,000 to 1 in 170,000 male births, Hunter Syndrome, is an X-linked disorder, of carbohydrate metabolism that occurs almost exclusively in males, with females as the carriers of the d...

Aug 26, 2016

The South San Francisco biotech startup, Denali Therapeutics, that had raised $217 million last year to fight Alzheimer’s, Parkinson’s and ALS, and an additional  $130 million from investors in a private placement led by Baillie Gifford, a UK-based mutual fund, has finally spoken about its plans to use the fund. The...